Skip to content

About
News
Clinicians
Patients
Research

Menu

About
News
Clinicians
Patients
Research

AMD Publications

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Menu

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based study

British Journal of Ophthalmology

August 2019

Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents

Ophthalmology

May 2019

Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration

Ophthalmology

January 2019

Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational Study

Retina

October 2018

A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! Project

Graefe’s Archive for Clinical and Experimental Ophthalmology

October 2018

Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project

American Journal of Ophthalmology

June 2018

Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational Study

Ophthalmology Retina

June 2018

Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence

Clinical and Experimental Ophthalmology

May 2018

Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term data set.

Clinical and Experimental Ophthalmology

April 2018

Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration

Ophthalmology

February 2018

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration

Ophthalmology

January 2018

Two year outcomes of “treat and extend” intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration

Retina

January 2018

« Previous Page1 Page2 Page3 Page4 Page5 Page6 Next »

Email: ssi.ssr@sydney.edu.au
Phone: (+61) 421 787 808

Level 1, South Block
Sydney Eye Hospital
8 Macquarie Street
Sydney NSW 2000

Follow us

X-twitter Facebook Youtube

Quick links

Contact Us
Donate Now

Contact Us
Donate Now